Discrimination and quantification of methotrexate in the presence of its metabolites in patient serum using SERS mapping, assisted by multivariate spectral data analysis

被引：5

作者：

Soufi G. ^{[1
,2
,3
]}

Dumont E. ^{[1
,2
]}

Göksel Y. ^{[1
,2
]}

Slipets R. ^{[1
,2
]}

Raja R.A. ^{[4
,5
]}

Schmiegelow K. ^{[4
,5
]}

Bagheri H. ^{[3
]}

Boisen A. ^{[1
,2
]}

Zor K. ^{[1
,2
]}

机构：

[1] Center for Intelligent Drug Delivery and Sensing Using Microcontainers and Nanomechanics (IDUN), Department of Health Technology, Technical University of Denmark, Kgs. Lyngby

[2] BioInnovation Institute Foundation, Copenhagen N

[3] Department of Chemistry, Sharif University of Technology, P.O. Box 11365-9516, Tehran

[4] Department of Paediatrics and Adolescent Medicine, Rigshospitalet University Hospital, Copenhagen

[5] Denmark and Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen

来源：

Biosensors and Bioelectronics: X | 2023年 / 14卷

关键词：

Biomolecules - Extraction - Least squares approximations - Multivariant analysis - Patient monitoring - Patient treatment - Phase separation - Raman scattering - Raman spectroscopy - Surface scattering;

D O I：

10.1016/j.biosx.2023.100382

中图分类号：

学科分类号：

摘要：

Therapeutic drug monitoring (TDM) of methotrexate (MTX), an anticancer drug, is critical since MTX therapy can lead to severe adverse effects if not monitored to ensure clearance. Discriminating and quantifying MTX among its metabolites is challenging, time consuming, and not universally available. Therefore, we propose a surface-enhanced Raman scattering (SERS) based method as a rapid and easy-to-use alternative to complex standard methods. We implemented a solid phase extraction (SPE) process in a syringe filter holder (μ-SPE-SFH), suitable for the extraction of MTX and compatible with nanopillar assisted separation (NPAS) and SERS-based detection. All of the parameters related to the extraction, desorption, and NPAS procedure were investigated and optimized. The SERS spectra from maps were analyzed with partial least squares as regression (PLSR) and as a discrimination analysis (PLS-DA) to enable, for the first time with SERS, the identification and quantification of MTX in the presence of its metabolites (7-hydroxy-methotrexate (7-OH MTX) and 2,4-diamino-N(10)-methylpteroic acid (DAMPA)). PLSR facilitated MTX quantification in patient samples in the presence of drugs that could be co-administered during MTX therapy. We found the detection limit to be 0.15 μM while the limit of quantification was 0.55 μM. In addition, for the PLSR, the accuracy, precision, analytical sensitivity, and inverse of analytical sensitivity were 0.66 μM, 0.5 μM, 10.5 μM−1, and 0.1 μM respectively. Furthermore, when quantifying MTX from patient samples, we found a good agreement between calculated MTX concentration with the developed method and reference assay, showing the potential of the sensor in clinical application. © 2023 The Authors

引用

共 52 条

[41]

Perumal J., Wang Y., Attia A.B.E., Dinish U.S., Olivo M., Towards a point-of-care SERS sensor for biomedical and agri-food analysis applications: a review of recent advancements, Nanoscale, 13, 2, pp. 553-580, (2021)

[42]

Piard C., Bressolle F., Fakhoury M., Zhang D., Yacouben K., Rieutord A., Jacqz-Aigrain E., A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia, Cancer Chemother. Pharmacol., 60, 4, pp. 609-620, (2007)

[43]

Ramsey L.B., Balis F.M., O'Brien M.M., Schmiegelow K., Pauley J.L., Bleyer A., Widemann B.C., Askenazi D., Bergeron S., Shirali A., Schwartz S., Vinks A.A., Heldrup J., Consensus guideline for use of glucarpidase in patients with high-dose methotrexate induced acute kidney injury and delayed methotrexate clearance, Oncol., 23, 1, pp. 52-61, (2018)

[44]

Risticevic S., Niri V.H., Vuckovic D., Pawliszyn J., Recent developments in solid-phase microextraction, Anal. Bioanal. Chem., 393, pp. 781-795, (2009)

[45]

Soldin O.P., Soldin S.J., Review: therapeutic drug monitoring in pediatrics, Ther. Drug Monit., 24, 1, (2002)

[46]

Subaihi A., Trivedi D.K., Hollywood K.A., Bluett J., Xu Y., Muhamadali H., Ellis D.I., Goodacre R., Quantitative online liquid chromatography-surface-enhanced Raman scattering (LC-SERS) of methotrexate and its major metabolites, Anal. Chem., 89, 12, pp. 6702-6709, (2017)

[47]

Svahn T., Mellgren K., Harila-Saari A., Asberg A., Kanerva J., Jonsson O., Vaitkeviciene G., Stamm Mikkelssen T., Schmiegelow K., Heldrup J., Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia, Pediatr. Blood Cancer, 64, 7, pp. 1-7, (2017)

[48]

Taudorf E.H., Lerche C.M., Erlendsson A.M., Philipsen P.A., Hansen S.H., Janfelt C., Paasch U., Anderson R.R., Haedersdal M., Fractional laser-assisted drug delivery: laser channel depth influences biodistribution and skin deposition of methotrexate, Laser Surg. Med., 48, 5, pp. 519-529, (2016)

[49]

Titato G.M., Lancas F.M., Comparison Between Different Extraction (LLE and SPE) and Determination (HPLC and Capillary-LC) Techniques in the Analysis of Selected PAHs in Water Samples, J. Liquid Chromatogr. Related Technol., 28, 19, pp. 3045-3056, (2006)

[50]

Viehrig M., Rajendran S.T., Sanger K., Schmidt M.S., Alstrom T.S., Rindzevicius T., Zor K., Boisen A., Quantitative SERS assay on a single chip enabled by electrochemically assisted Regeneration: a method for detection of melamine in milk, Anal. Chem., 92, 6, pp. 4317-4325, (2020)

← 1 2 3 4 5 6 →